Laryxin Menthol (Chlorhexidine Gluconate, Lidocaine Hydrochloride Monohydrate)

Chlorhexidine gluconate acts by binding to bacterial cell membranes, disrupting their structure and causing leakage of intracellular contents, which leads to bacterial cell death. This broad‑spectrum activity helps lower the microbial population in the mouth, supporting oral hygiene and reducing infection risk.

The appropriate dose of Laryxin Menthol is determined by the prescribing healthcare professional based on the specific indication, patient age, and condition severity. Users should follow the instructions provided on the product label or those given by their clinician and should not exceed the recommended amount.

Safety data for Laryxin Menthol in pregnancy and lactation are limited. It is classified as having an unknown pregnancy category, so it should only be used when the potential benefit justifies any possible risk to the fetus. Breastfeeding mothers should consult their healthcare provider before use.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity of Laryxin Menthol. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with single‑ingredient antiseptics, Laryxin Menthol offers the combined benefits of chlorhexidine’s potent antibacterial action and lidocaine’s local anaesthetic effect, providing both hygiene and pain relief in one product. This dual action can be more convenient than using separate antiseptic and analgesic preparations.

Laryxin Menthol should be stored at ambient temperature below 25 °C, in its original packaging, protected from moisture and direct sunlight. Keep the container tightly closed when not in use to maintain product stability and prevent contamination.

The product is applied directly to the oral mucosa using the supplied applicator or by swabbing the affected area. It is intended for oromucosal use only; users should avoid swallowing large amounts and follow the label directions or healthcare professional’s guidance.

Serious adverse reactions, although rare, include allergic contact dermatitis, severe oral irritation or ulceration, and anaphylaxis. If any signs of a severe allergic response such as difficulty breathing, swelling of the face or throat, or extensive mucosal damage occur, discontinue use and seek immediate medical attention.

Individuals with known hypersensitivity to chlorhexidine, lidocaine, or any excipients in the formulation should avoid using Laryxin Menthol. It is also contraindicated for patients with extensive oral ulcerations where the product may exacerbate irritation, and it should be used with caution in pregnant or breastfeeding women.